Nanomotors are small devices that have been developed with the help of recent advancements in science and technology for the betterment of healthcare systems as novel disease therapy and therapeutics. They employ various technologies and techniques to perform their functions in the delivery of drugs, including modifying the location of the motor to increase cell orientation and internalization. Synthetic nanomotors have been designed as a multifunctional superparamagnetic/catalytic micro robot (PM/Pt mini robots) and are being used for cell manipulation and drug delivery such as anticancer agents. Nanomotors have the potential to revolutionize cancer research and treatment. They can be designed to target specific biomarkers in cancer cells, enabling early detection and real-time monitoring of the disease. They can also offer a non-invasive method for diagnosis. The use of nanomotors may reduce the need for invasive treatments like biopsies, resulting in less discomfort for patients and quicker diagnosis timeframes. Additionally, nanomotors in cancer treatment, can facilitate the deep penetration of medications into sick tissues and promote normalization of the tumor vascular system and the destruction of the intrinsic extracellular matrix. This has been shown to increase the capacity of T cell tumor infiltration in vivo. Overall, nanomotors have the potential to revolutionize the way cancer is diagnosed and treated. They can offer targeted drug delivery, early cancer detection, and minimize invasive surgery. The use of nanomotors may reduce discomfort for patients and improve cancer outcomes. Worldwide rise in cancer morbidity and mortality rates are observed, and nanomotors may provide new opportunities for improving cancer remediation and further work on nanomotors may provide new avenues for combating this disease